These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1908 related articles for article (PubMed ID: 7852655)
1. Hyperthermic isolated limb perfusion with intra-arterial administration of carboplatin and/or interferon-beta for the treatment of malignant melanoma of the leg. Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y J Dermatol; 1994 Nov; 21(11):915-22. PubMed ID: 7852655 [TBL] [Abstract][Full Text] [Related]
2. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon. Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252 [TBL] [Abstract][Full Text] [Related]
3. Systemic effects of hyperthermic isolated lower limb perfusion with carboplatin and interferon-beta. Tominaga R; Nakano T; Shibata S; Siraishi K; Nagae S; Nakayama J; Yasui H Artif Organs; 2001 Jan; 25(1):36-41. PubMed ID: 11167557 [TBL] [Abstract][Full Text] [Related]
4. Current techniques of hyperthermic isolated limb perfusion for malignant melanoma. Tominaga R; Kohno H; Mayumi H; Shiraishi K; Nagae S; Nakayama J; Yasui H Surg Today; 2000; 30(4):339-42. PubMed ID: 10795866 [TBL] [Abstract][Full Text] [Related]
5. Hyperthermic isolated regional perfusion of the limb with carboplatin. Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic hyperthermic limb perfusion in stage I melanoma. Krige JE; King HS; Strover RM Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834 [TBL] [Abstract][Full Text] [Related]
8. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients]. Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498 [TBL] [Abstract][Full Text] [Related]
9. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730 [TBL] [Abstract][Full Text] [Related]
10. Phase I-II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremities. Hajarizadeh H; Mueller CR; Woltering EA; Small K; Fletcher WS Melanoma Res; 1991; 1(1):55-61. PubMed ID: 1822770 [TBL] [Abstract][Full Text] [Related]
11. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment. Hoekstra HJ; Schraffordt Koops H; de Vries LG; van Weerden TW; Oldhoff J Cancer; 1993 Aug; 72(4):1224-9. PubMed ID: 8393368 [TBL] [Abstract][Full Text] [Related]
12. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities. Jönsson PE; Hafström L; Hugander A Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009 [No Abstract] [Full Text] [Related]
14. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis. Di Filippo F; Rossi CR; Santinami M; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Angelo P; Pasqualoni R; Di Filippo S In Vivo; 2006; 20(6A):739-42. PubMed ID: 17203758 [TBL] [Abstract][Full Text] [Related]
15. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb. Skene AI; Bulman AS; Williams TR; Thomas JM; Westbury G Br J Surg; 1990 Jul; 77(7):765-7. PubMed ID: 2383752 [TBL] [Abstract][Full Text] [Related]
17. Increase in the peripheral lymphocyte populations expressing CD54 (ICAM-1) after hyperthermic isolated limb perfusion in patients with malignant melanoma: an analysis of four cases. Nakayama J; Guan XC; Tominaga R; Nagae S; Matsuda K; Nakao T; Rikihisa W; Yang HH; Shibata S; Eguchi A; Takeuchi S; Hori Y; Yasui H; Takahashi S J Dermatol Sci; 1998 May; 17(1):33-8. PubMed ID: 9651826 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities. Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048 [TBL] [Abstract][Full Text] [Related]
19. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a]. Kirchner HH; Atzpodien J; Poliwoda H Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119 [TBL] [Abstract][Full Text] [Related]